Last update :
19/11/2024
Local anesthetic   Bupivacaine hydrochloride  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Bicain Finland
Bucain Austria, Germany
Bucaine Saudi Arabia
Bupi Alleman Germany
Bupinest Colombia, Ecuador
Bupirop Ecuador
Bupisen Italy
Bupivacain Germany
Bupivacaina Chile, Spain
Bupivacaine Australia, Great Britain, Ireland, Morocco, Tunisia
Bupivan Chile, Germany
Buvacaina Mexico
Buvasin Turkey
Carbostesin Austria, Germany
Dolanaest Austria, Germany
Duracaine Argentina
Inibsacain Spain
Marcain Australia, Denmark, Egypt, Malaysia, New Zealand
Marcaine Belgium
Sensorcaine Canada
Sinebupiv Ecuador
References   injection   References : Bupivacaine hydrochloride  
Type Publication
60 Journal Tu YH, Stiles ML, Allen LV Jr.
Stability of fentanyl citrate and bupivacaine hydrochloride in portable pump reservoirs.
Am J Hosp Pharm 1990 ; 47: 2037-2040.
217 Journal Allen LV, Stiles ML, Wang DP, Tu YH.
Stability of bupivacaine hydrochloride, epinephrine hydrochloride, and fentanyl citrate in portable infusion-pump reservoirs.
Am J Hosp Pharm 1993 ; 50: 714-715.
220 Journal Johnson CE, Christen C, Perez MM, Ma M.
Compatibility of bupivacaine hydrochloride and morphine sulfate.
Am J Health-Syst Pharm 1997 ; 54: 61-64.
221 Journal Neels JT.
Compatibility of bupivacaine hydrochloride with hydromorphone hydrochloride or morphine sulfate.
Am J Hosp Pharm 1992 ; 49: 2149.
293 Journal Jones JW, Davis AT.
Stability of bupivacaine hydrochloride in polypropylene syringes.
Am J Hosp Pharm 1993 ; 50: 2364-2365.
306 Journal Christen C, Johnson CE, Walters JR.
Stability of bupivacaine hydrochloride and hydromorphone hydrochloride during simulated epidural coadministration.
Am J Health-Syst Pharm 1996 ; 53: 170-173.
346 Journal Wulf H, Gleim M, Mignat C.
The stability of mixtures of morphine hydrochloride, bupivacaine hydrochloride, and clonidine hydrochloride in portable pump reservoirs for the management of chronic pain syndromes.
J Pain Symptom Manage 1994 ; 9: 308-311.
507 Journal Dawson PJ, Bjorksten AR, Duncan IP, Barnes RK, Beemer GH.
Stability of fentanyl, bupivacaine and adrenaline solutions for extradural infusion.
Br J Anaesth 1992 ; 68: 414-417.
510 Journal Roos PJ, Glerum JH, Schroeders MJH.
Effect of glucose 5% solution and bupivacaine hydrochloride on absorption of sufentanil citrate in a portable pump reservoir during storage and simulated infusion by an epidural catheter.
Pharm World Sci 1993 ; 15: 269-275.
512 Journal Barnes AR, Nash S.
Stability of bupivacaine hydrochloride with diamorphine hydrochloride in an epidural infusion.
Pharm World Sci 1995 ; 17: 87-92.
529 Journal Van Asten P, Glerum JH, Spaanderman ER, Van Niekerk J, Van Dijk A.
Compatibility of bupivacaine and iohexol in two mixtures for paediatric regional anaesthesia.
Pharm Weekbl [Sci] 1991 ; 13: 254-256.
1276 Journal Shiffman E, Walker SE, Yoon T, Yeung M.
Stability and compatibility of morphine with bupivacaine.
Can J Hosp Pharm 1998 ; 51: 110-116.
1292 Journal Grassby PF, Roberts DE.
Stability of epidural opiate solutions in 0.9 per cent sodium chloride infusion bags.
Int J Pharm Pract 1995 ; 3: 174-177.
1491 Journal Brouwers JRBJ, van Doorne H, Meevis RF, Boersma FP.
Stability of sufentanil citrate and sufentanil citrate/bupivacaine mixture in portable infusion pump reservoirs.
Eur Hosp Pharm 1995 ; 1: 12-14.
1707 Journal Trissel LA, Xu QA, Pham L.
Physical and chemical stability of low and high concentrations of morphine sulfate with bupivacaine hydrochloride packaged in plastic syringes.
Int J Pharm Compound 2002 ; 6: 70-73.
1723 Journal Sattler A, Jage J, Krämer I.
Physico-chemical stability of infusion solutions for epidural administration containing fentanyl and bupivacaine or lidocaine.
Pharmazie 1998 ; 53: 386-391.
1875 Journal Kjonniksen I, Brustugun J, Breivik H, Anderssen E, Klem W.
Stability of an epidural analgesic solution containing adrenaline, bupivacaine and fentanyl.
Acta Anaesthesiol Scand 2000 ; 44: 864-867.
1879 Journal Hildebrand KR, Elsberry DE, Deer TR.
Stability, compatibility, and safety of intrathecal bupivacaine administered via an implantable delivery system.
Clin J Pain 2001 : 17: 239-244.
1885 Journal Essink-Tjebbes CM, Burger DM, Beelen, Wuis EW, Heckster YA.
Long-term stability of morphine and bupivacaine mixture for spinal use.
Pharm World Sci 1999 ; 21: 144-146.
1909 Journal Farhang-Asnefi S, Barre J, Callaert S, Boutros A, Causse R, Thebault A.
Compatibilité et stabilité du mélange bupivacaïne-sufentanil en poche.
J Pharm Clin 2000 ; 19: 248-251.
1931 Journal Donnely RF.
Physical compatibility and chemical stability of bupivacaine and hydromorphone in polypropylene syringes.
Can J Hosp Pharm 2004 ; 4: 230-235.
1948 Journal Classen AM, Wimbish GH, Kupiec TC.
Stability of admixtures containing morphine sulfate, bupivacaine hydrochloride, and clonidine hydrochloride in an implantable infusion system.
J Pain Symptom Manage 2004 ; 28, 6: 603-611.
2083 Journal La Forgia SP, Sharley NA, Burgess NG, Doecke CJ.
Stability and compatibility of morphine, midazolam and bupivacaine combinaisons for iontravenous infusion.
J Pharm Pract and Res 2002 ; 32: 65-68.
2252 Journal Shields D, Montenegro R, Aclan J.
Chemical stability of admixture combining ziconotide and bupivacaine during simulated intrathecal administration.
Neuromodulation 2007 ; 10, 1: 1-5.
2305 Journal Bianchi F, Ginggen A, Tardy Y.
Stability and compatibility of drug mixtures in an implantable infusion system.
Anaesthesia 2008 63, 9: 972-978.
2306 Journal Priston M.J, Hughes J.M, Santillo M, Christie I.W.
Stability of an epidural analgesic admixture containing epinephrine, fentanyl and bupivacaine.
Anaesthesia 2004 ; 59, 10: 979-983.
2307 Journal Kreeger L, Cowin P, Noble-Gresty J, Naysmith A.
Epidural diamorphine and bupivacaine stability study.
Palliative Med 1995 ; 9, 4: 315-318.
2308 Journal Hudson S.J, Jones M.F, Nolan S, Ellis H, Duncombe R, Alexander-Williams J.M.
Stability of premixed syringes of diamorphine and hyperbaric bupivacaine.
Int J Obstet Anesth 2005 ; 14, 4: 284-287.
2319 Journal Janssen K, Wisselo R, Geerlings C, Schouten J.P.
Chemical stability of a solution of bupivacaine hydrochloride 0.125% and sufentanil citrate 0.5 µg/ml for filling syringes using a repeater pump.
EJHP Science 2009 ; 15, 1: 11-14.
3131 Journal Donnely RF, Wong K, Spencer J.
Physical compatibility of high-concentration bupivacaine with hydromorphone, morphine and fentanyl.
Can J Hosp Pharm 2010 ; 63, 2: 154-155.
3184 Manufacturer
Hyaluronidase (Hyalase®) - Summary of Product characteristics.
CP Pharmaceuticals 2005
3296 Journal Salmeron-Garcia A, Navas N, Martin A, Roman E, Cabeza J, Capitan-Vallvey L.F
Determination of Tramadol, Metamizole, Ropivacaine, and Bupivacaine in Analgesic Mixture Samples by HPLC with DAD Detection.
J Chromatographic Sci 2009 ; 47: 1-7.
3372 Journal Hanci V, Ali Kiraz H, Ömür D, Ekin S, Uyan B, Yurtlu B.S.
Precipitation in Gallipoli: Sugammadex / Amiodarone & Sugammadex / Dobutamine & Sugammadex / Protamine.
Rev Bras Anestesiol 2013 ; 63, 1: 163-166.
3964 Journal Audet M.A, Forest E, Friciu M, Forest J.M, Leclair G.
Compatibilité du citrate de caféine injectable avec plusieurs autres médicaments.
Pharmactuel 2017 ; 50,1 : 27-33.
4200 Journal Macorigh C, Guibbert V, Casanova M, Haenni C.
Stability study of hydromorphone and bupivacaine mixture by HPLC-UV.
EJHP 2018
4319 Journal Lessard J-J, Caron E, Schérer H, Forest J-M, Leclair G.
Compatibility of Y-site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs.
Hosp Pharm 2020 ; 55, 5: 332-337.
4603 Journal Vallée M, Barthélémy I, Friciu M, Pelletier E, Forest J.M, Benoit F, Leclair G.
Compatibility of Lactated Ringer’s Injection With 94 Selected Intravenous Drugs During Simulated Y-site Administration.
Hosp Pharm 2021 ; 56, 4: 228-234.
4746 Poster Shead K, Derrick H, Lyons D, Law S, Ma N.H.
Stability and Compatibility of Bupivacaine and Hydromorphone in PVC and non-DEHP bags for 30 days at 4°C and 25°C.
2023

  Mentions Légales